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Abstract
Background: Maternal pre-pregnancy body mass index (BMI) is positively associated
with offspring birth weight (BW) and BMI in childhood and adulthood. Each of these
associations could be due to causal intrauterine effects, or confounding (genetic or
environmental), or some combination of these. Here we estimate the extent to which the
association between maternal BMI and offspring body size is explained by offspring ge-
notype, as a first step towards establishing the importance of genetic confounding.
Methods: We examined the associations of maternal pre-pregnancy BMI with offspring
BW and BMI at 1, 5, 10 and 15 years, in three European birth cohorts (n 11 498).
Bivariate Genomic-relatedness-based Restricted Maximum Likelihood implemented in
the GCTA software (GCTA-GREML) was used to estimate the extent to which phenotypic
covariance was explained by offspring genotype as captured by common imputed single
nucleotide polymorphisms (SNPs). We merged individual participant data from all
cohorts, enabling calculation of pooled estimates.
Results: Phenotypic covariance (equivalent here to Pearson’s correlation coefficient) be-
tween maternal BMI and offspring phenotype was 0.15 [95% confidence interval (CI):
0.13, 0.17] for offspring BW, increasing to 0.29 (95% CI: 0.26, 0.31) for offspring 15 year
BMI. Covariance explained by offspring genotype was negligible for BW [–0.04 (95% CI:
–0.09, 0.01)], but increased to 0.12 (95% CI: 0.04, 0.21) at 15 years, which is equivalent to
43% (95% CI: 15%, 72%) of the phenotypic covariance. Sensitivity analyses using weight,
BMI and ponderal index as the offspring phenotype at all ages showed similar results.
Conclusions: Offspring genotype explains a substantial fraction of the covariance be-
tween maternal BMI and offspring adolescent BMI. This is consistent with a potentially
important role for genetic confounding as a driver of the maternal BMI–offspring BMI
association.
Key words: Maternal, offspring, BMI, genetic confounding, NFBCs, ALSPAC
Introduction
It has been hypothesized that development in the uterus of
an obese mother may programme a fetus for increased risk
of obesity in subsequent postnatal life.1–3 Accordingly, in-
tervening to prevent maternal obesity prior to pregnancy
has been proposed as a means to reduce obesity risk in the
offspring.4–6 Maternal body mass index (BMI) or obesity
pre- or during pregnancy is associated with offspring
adiposity measures at birth,7 in childhood8–15 and in adult-
hood,16,17 as well as offspring cardiometabolic risk factors
and outcomes.12,16,18–20 However, these associations could
be due to confounding, either by environmental factors or
by maternal genotype inherited by the offspring.
Furthermore, the contribution of causal intrauterine
effects, genetic confounding and environmental confound-
ing could be different for each of these associations.
Key Messages
• Maternal body mass index (BMI) is associated with offspring weight at birth and BMI in childhood and adulthood
• Each of these associations could be due to causal intrauterine effects, or confounding (genetic or environmental), or
to some combination of these
• Our study suggests that a substantial part of the maternal BMI–offspring BMI association is explained by offspring ge-
notype, but that in contrast the maternal BMI–offspring birth weight association is not explained by offspring
genotype
• This is a first step towards establishing the importance of genetic confounding of the maternal BMI–offspring BMI
association
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Mendelian randomization (MR)21 evidence suggests
that greater maternal BMI is likely to cause, via intrauter-
ine mechanisms, greater offspring weight and ponderal in-
dex (PI) at birth.22 However, the balance of evidence from
MR,11,23 within sibship analyses,24,25 and paternal nega-
tive exposure control studies8–13,26 suggests that maternal
BMI is not causally related to offspring BMI in later life. It
is therefore likely that confounding explains the associa-
tion between maternal BMI and offspring child/adolescent
adiposity but not offspring birth adiposity.
In published studies adjustment for numerous poten-
tial confounders makes a negligible difference to the
strength of the association between maternal (pre-)preg-
nancy adiposity and offspring adiposity in childhood or
adulthood9,11,12,24,26–35 (Supplementary Note S1 and
Supplementary Table S1, available as Supplementary
data at IJE online). This could be because the confound-
ers that were adjusted for were measured poorly, or be-
cause other unmeasured confounders explain the
association; maternal genotype inherited by the offspring
could be an important unmeasured confounder. General
population data suggest that the narrow-sense heritabil-
ity [the proportion of phenotypic variance due to addi-
tive genetic effects (denoted by h2)] of BMI is at least
30%,36,37 with higher estimates from family (45%)
and twin (75%) studies.38,39 It is plausible therefore
that the direct effects of alleles shared by the mother
and offspring explain a substantial part of the maternal
BMI–offspring BMI association; we refer to this as ge-
netic confounding (Figure 1).
Here we aimed to estimate the extent to which the co-
variance between maternal BMI and offspring body size
from birth to adolescence is explained by offspring geno-
type, as a first step towards establishing the importance of
genetic confounding.
Methods
Study design
We analysed data from three prospective population-based
birth cohorts: the Northern Finland Birth Cohort (NFBC)
1966,41 NFBC198642 and Avon Longitudinal Study of
Parents and Children (ALSPAC).43,44 Details of sample re-
cruitment are given in Supplementary Note S2, available as
Supplementary data at IJE online. Ethical approval for
NFBC1966 and NFBC1986 was obtained from the
University of Oulu Ethics Committee and the Ethical
Committee of the Northern Ostrobothnia Hospital
District, and for ALSPAC was obtained from the ALSPAC
Ethics and Law Committee and the Local Research Ethics
Committees.
Exclusion criteria
We excluded stillbirths, multiple births and individuals
with missing genotype data, and removed one member
of any sibling pairs present at random. We then excluded
participants with missing maternal BMI or offspring
BMI/birth weight (BW) data. For our main analyses we
used Genomic-relatedness-based Restricted Maximum
Likelihood implemented in the GCTA software (GCTA-
GREML), which requires that cryptic (unknown) relat-
edness be removed to avoid confounding due to
familial environment and non-additive genetic effects.45
After merging data from the three cohorts we removed
one individual from each cryptically related pair using a
relatedness threshold of 0.05, resulting in inclusion of
up to 11 498 participants (Supplementary Note S3 and
Figure S4, available as Supplementary data at IJE
online).
Figure 1. Directed acyclic graph (DAG) showing genetic confounding of
the maternal BMI–offspring BMI association. The potentially causal as-
sociation of interest is between maternal BMI and offspring BMI. The
genetic confounding path (maternal BMI  maternal genotype ! off-
spring genotype ! offspring BMI) results from direct effects of mater-
nal genotype on maternal BMI and direct effects of offspring genotype
on offspring BMI, as well as inheritance of maternal alleles by the off-
spring. We use the term genetic confounding to refer to only the afore-
mentioned path; although another potential confounding path involves
genotype (i.e. maternal BMI  maternal genotype ! other maternal
phenotypes! offspring BMI), this latter path involves variables that are
non-genetic from the offspring’s perspective. In the DAG, variables
used in the present analysis are in bold lettering; other variables that
we have not included in our analyses are italicized. Given that we in-
clude only offspring genotype, and not maternal genotype, in our analy-
ses we are unable to distinguish genetic confounding from maternal
genetic effects [i.e. indirect effects of maternal genotype on offspring
BMI, mediated by the offspring’s prenatal or postnatal environment40
(dashed arrows)]; both could result in genetic covariance (Methods) be-
tween maternal BMI and offspring BMI.
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Genotyping, quality control and imputation
Genotyping was carried out using genome-wide microar-
ray chips followed by standard quality control (QC) proce-
dures; details of genotyping and QC for each cohort are
given in full in Supplementary Note S5, available as
Supplementary data at IJE online. During QC, individuals
with non-European ancestry were excluded. For all three
cohorts, array genotypes were harmonized and imputed to
the Haplotype Reference Consortium (HRC) imputation
reference panel46 via the Michigan imputation server.47
Maternal and offspring BW and BMI
For our primary analyses we examined the associations of
maternal pre-pregnancy BMI with offspring weight at birth,
and BMI at 1, 5, 10 and 15 years, in all studies
(Supplementary Note S6, Table 1 and Supplementary Table
S7, available as Supplementary data at IJE online). We also
analysed BMI data at 31 and 46 years in NFBC1966. We
calculated maternal pre-pregnancy BMI using pre-
pregnancy weight reported by the mothers during early
pregnancy and either self-reported or measured height
(Supplementary Table S8, available as Supplementary data
at IJE online). Offspring sex, BW, length and gestational
age were obtained from the birth record or measured by re-
search staff (Supplementary Table S8, available as
Supplementary data at IJE online). In childhood and adult-
hood offspring weight and height were obtained from clini-
cal examination, growth records or questionnaires
(Supplementary Table S8, available as Supplementary data
at IJE online). For all weight, height and BMI variables we
set outlying values that we judged to be physiologically im-
plausible to missing. We standardized maternal and off-
spring phenotypic variables to give mean zero and variance
one in the pooled dataset, using the usual formula
(Supplementary Note S9, available as Supplementary data
at IJE online). With standardized variables, phenotypic co-
variance is equivalent to phenotypic correlation, enabling
direct comparison of phenotypic covariance for offspring
phenotypes that are measured in different units. Although
BMI variables were positively skewed, sensitivity analyses
indicated that results were similar when using a variety of
normalizing transformations (Supplementary Note S10 and
Figure S11, available as Supplementary data at IJE online),
therefore we used untransformed variables for our primary
analyses. Supplementary Note S12, available as
Supplementary data at IJE online, gives details of other
pregnancy variables that we used in sensitivity analyses.
Table 1. Phenotypic characteristics of the mothers and offspring. Sample sizes are the same as for the main analyses.
Supplementary Note S39, available as Supplementary data at IJE online gives more detailed characteristics of the mothers and
offspring.
Cohort n Phenotype Age Offspring sex
Mean SD Mean SD Male Female
NFBC1966 2894 Maternal BMI (kg/m2) 23.0 3.3 Maternal age at offspring birth (years) 27.6 6.3
NFBC1986 2094 22.2 3.3 28.0 5.3
ALSPACa 6510 22.9 3.8 29.4 4.6
NFBC1966 2894 Birth weight (g) 3510 520 Gestational age at birth (weeks) 40.1 1.9 48.3% 51.7%
NFBC1986 2094 3610 490 40.0 1.5 49.3% 50.7%
ALSPACa 6510 3450 520 39.5 1.7 51.2% 48.8%
NFBC1966 2736 1 year BMI (kg/m2) 17.8 1.6 Age at BMI measurement (years) 1.0 0.1 48.2% 51.8%
NFBC1986 1838 17.3 1.4 1.0 0.1 49.0% 51.0%
ALSPACa 6159 17.5 1.5 0.9 0.2 51.2% 48.8%
NFBC1966 2145 5 year BMI (kg/m2) 15.5 1.4 5.1 0.8 49.4% 50.6%
NFBC1986 1840 15.8 1.5 5.0 0.4 49.2% 50.8%
ALSPACa 5930 16.2 1.5 4.1 0.7 51.3% 48.7%
NFBC1966 2146 10 year BMI (kg/m2) 17.0 2.3 10.4 0.8 50.0% 50.0%
NFBC1986 1793 17.6 2.7 9.9 0.6 49.5% 50.5%
ALSPACa 5494 17.7 2.8 9.9 0.5 50.2% 49.8%
NFBC1966 2866 15 year BMI (kg/m2) 19.7 2.6 14.7 0.5 48.0% 52.0%
NFBC1986 2107 21.3 3.7 16.0 0.4 48.6% 51.4%
ALSPACa 4902 21.0 3.5 14.9 0.9 49.3% 50.7%
NFBC1966 3711 31 year BMI (kg/m2) 24.6 4.2 31.1 0.3 47.6% 52.4%
NFBC1966 3079 46 year BMI (kg/m2) 26.9 5.0 46.5 0.6 44.4% 55.6%
aALSPAC offspring were born between 1991 and 1992.
SD, standard deviation.
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Estimation of genetic and residual covariance
We used bivariate GCTA-GREML to estimate the extent
to which the phenotypic covariance between maternal BMI
and offspring phenotype was explained by imputed off-
spring single nucleotide polymorphisms (SNPs). The sim-
plest GCTA-GREML model is a univariate model48 that
estimates the phenotypic variance explained by a set of
genome-wide SNPs (termed the SNP heritability). Like
other heritability estimation methods, GCTA-GREML
exploits the fact that for heritable phenotypes, genetically
similar individuals are likely to be phenotypically similar.
Traditional heritability estimation methods use probability
theory to infer expected genetic similarity between close
relatives in pedigrees,45,49 and the phenotypic variance
explained by all genetic variants is estimated. In contrast,
in GCTA-GREML the genetic similarity between pairs of
distantly related individuals is calculated directly from a
set of SNPs, which enables utilization of non-pedigree sam-
ples. However, the phenotypic variance explained by only
those genetic variants that are tagged by the set of SNPs is
estimated. Accordingly, the two approaches estimate dif-
ferent quantities, and GCTA-GREML estimates are usu-
ally somewhat lower than pedigree-based heritability
estimates.36–39 GCTA-GREML has been widely applied to
diverse phenotypes.37,50–53
GCTA-GREML has been extended to a bivariate
model that partitions the phenotypic covariance between
two traits,54 and has again been widely applied to di-
verse phenotypes.51,55–58 Often these studies report the
genetic correlation (rG) between two phenotypes, which
quantifies the extent to which the additive genetic effects
on phenotype one are shared with those on phenotype
two (Supplementary Note S15, available as
Supplementary data at IJE online). However, bivariate
GCTA-GREML also enables estimation of the propor-
tion of phenotypic covariance that is explained by the set
of SNPs. This has previously been applied to two pheno-
types measured in the same individual.56,59 In the pre-
sent study we exploited this approach, but instead
partitioned the phenotypic covariance between maternal
BMI and offspring phenotype. In typical bivariate
GCTA-GREML analyses, trait one, trait two and geno-
type are measured in the same individual, therefore the
unit of analysis is the individual. In our analyses, geno-
type and trait one (offspring phenotype) were measured
in the offspring and trait two (maternal BMI) was mea-
sured in the mother, therefore the unit of analysis was
the mother–offspring dyad.
Assuming independence between additive genetic effects
and other contributing factors, we can partition the pheno-
typic covariance as follows:
CovP ¼ CovG þ CovE (Equation 1)
where CovP is the covariance between maternal BMI and
offspring phenotype (BW or BMI) estimated using the usual
formula (Supplementary Note S9, available as
Supplementary data at IJE online), CovG is the contribution
to this covariance from additive genetic effects captured by
the offspring’s imputed SNPs genome-wide, estimated using
bivariate GCTA-GREML54 and CovE is the residual (unex-
plained) covariance, which is a combination of additive ge-
netic effects not captured by SNPs, non-additive genetic
effects and environmental effects (the latter would be re-
ferred to as common environmental effects in the quantita-
tive genetics literature, because by definition common
environmental effects are those that cause relatives to be
more similar phenotypically). A detailed description of our
statistical approach is given in Supplementary Note S9,
available as Supplementary data at IJE online.
The ratio of CovG to CovP is our quantity of interest
and has been termed the bivariate heritability60 or coherit-
ability61 in the quantitative genetics literature. When both
CovG and CovE have the same sign, CovG:CovP is equiva-
lent to the proportion of phenotypic covariance that is
explained by additive genetic effects. If CovG and CovE are
opposite in sign then CovG:CovP may be negative or >1; in
this case CovG:CovP cannot be interpreted as a proportion,
but still gives an indication of the extent to which pheno-
typic covariance is explained by genotype.
GCTA-GREML requires computation of a genetic relat-
edness matrix (GRM) containing a SNP-based estimate of
relatedness for each pair of individuals in the sample. We
used imputed autosomal SNPs with minor allele frequency
(MAF) >0.01, imputation quality score (r2) >0.3 and lack
of evidence for Hardy-Weinberg disequilibrium (P>1e-6);
hard called (best-guess) genotypes (as output by the mini-
mac3 software package47) were used to construct the
GRM. Hard calls are integer values representing the most
likely genotype, and are assigned by minimac3 based on
the imputed haplotype probabilities. We fitted the GCTA-
GREML model using a single GRM. Twenty ancestry in-
formative principal components (PCs) calculated from the
GRM were included as fixed effects in all models to adjust
for population stratification; cohort, offspring sex and age
at phenotype measurement (replaced with gestational age
at birth for BW models) were also included as fixed effects.
We conducted sensitivity analyses (Supplementary
Notes/Tables/Figures S10, S11 and S16–S33, available as
Supplementary data at IJE online) to examine the impact of
1. alternative phenotype transformations including rank-
based inverse-normal transformation, natural loga-
rithm and UK-WHO z-scores
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2. using different MAF and imputation r2 thresholds, as
well as only directly genotyped (array) SNPs
3. varying the other covariates, as well as the number of
PCs, that were fitted as fixed effects
4. varying the relatedness exclusion threshold
5. using alternative phenotypes including weight, BMI
and PI [weight (kg)/height (m)3] at all ages.
We also tested for inflation of SNP heritability estimates
due to cryptic relatedness or population stratification62,63
(Supplementary Note S34 and Supplementary Table S35,
available as Supplementary data at IJE online). All analy-
ses were performed using the GCTA software package64
version 1.91.1 with the ‘reml-no-constrain’ option; results
were similar when we did not use this option.
Estimation of confidence intervals and meta-
analysis
The GCTA software supplies standard error (SE) estimates
for CovG, but not for CovG:CovP; we therefore used a
leave-one-out jackknife procedure65,66 to estimate all SEs,
and calculated 95% confidence intervals (CIs) as the point
estimate 6 1.96 x SE (Supplementary Note S36, available
as Supplementary data at IJE online). We confirmed via
simulation that the jackknife approach is likely to give CIs
with good coverage properties for a ratio of covariances
(Supplementary Note S37, available as Supplementary
data at IJE online). We merged individual participant data
(IPD) from the three cohorts and fitted the GCTA-GREML
model on this pooled dataset. In the meta-analysis litera-
ture this is referred to as one-stage IPD meta-analysis,67
and has also been referred to as mega-analysis, however
for simplicity we use the term ‘pooled IPD estimates’ here.
These pooled IPD estimates had greater statistical
efficiency than a standard meta-analysis in which the
GCTA-GREML model is fitted separately for each cohort,
followed by estimation of the pooled effect using a fixed or
random effects model. However, our pooled IPD estimates
assumed that the three cohorts were from the same popula-
tion. As a sensitivity analysis we therefore conducted a
standard meta-analysis using a random effects model
(DerSimonian and Laird68) which relaxed this assumption.
Analyses were conducted in Stata version 13.1 (StataCorp,
College Station, Houston, USA) and R version 3.5.0.69
Results
Sample characteristics
Table 1 shows the sample characteristics. Prevalence of
maternal obesity (BMI30) was 3.7% (95% CI: 3.0%,
4.4%) in NFBC1966, 3.2% (95% CI: 2.4%, 3.9%) in
NFBC1986 and 5.4% (95% CI: 4.9%, 6.0%) in ALSPAC.
Maternal BMI was associated with several non-genetic po-
tential confounders (Supplementary Table S39, available
as Supplementary data at IJE online).
Phenotypic and genetic covariance
Table 2 shows correlations between maternal and offspring
phenotypic variables. There were weak to moderate corre-
lations between all phenotypes, with stronger correlations
for temporally adjacent BMI phenotypes. Figure 2 shows
pooled IPD estimates from the combined cohorts for the
phenotypic covariance (CovP), genetic covariance (CovG)
and the ratio of genetic to phenotypic covariance
(CovG:CovP) between maternal BMI and offspring pheno-
type. Phenotypic covariance was 0.15 (95% CI: 0.13,
0.17) for offspring BW, decreasing to 0.10 (95% CI: 0.08,
0.12) for offspring 1 year BMI before increasing to 0.29
(95% CI: 0.26, 0.31) for offspring 15 year BMI.
Covariance explained by offspring genotype was negligible
for BW [–0.04 (95% CI: –0.09, 0.01)] but increased over
childhood, reaching 0.12 (95% CI: 0.04, 0.20) at 10 years
and 0.12 (95% CI: 0.04, 0.21) at 15 years, which is equiva-
lent to 44% (95% CI: 16%, 71%) and 43% (95% CI:
15%, 72%) of the phenotypic covariance at 10 and
15 years respectively. This pattern continued into adult-
hood, with high CovG:CovP estimated in NFBC1966 at
31 years [1.25 (95% CI: 0.35, 1.37)] and 46 years [0.78
(95% CI: –0.46, 1.87)], albeit with wide confidence inter-
vals (Supplementary Table S40, available as
Supplementary data at IJE online).
Sensitivity analyses
Standard meta-analysis using a random effects model gave
similar estimates to the pooled IPD estimates, although
with wider confidence intervals (Supplementary Notes/
Tables/Figures S41–S47, available as Supplementary data
at IJE online), and estimates changed little as we varied
covariates, phenotypes (weight, BMI or PI) or normalizing
transformations (Supplementary Notes/Figures S10, S11,
S20, S30–S33, available as Supplementary data at IJE on-
line). Results from analyses in which we varied the related-
ness exclusion threshold or the set of SNPs used to
calculate the GRM suggested that our primary analyses are
unlikely to be substantively biased, and estimates for
CovG:CovP and SNP heritability were not attenuated as we
varied the number of PCs fitted as fixed effects between
zero and one thousand (Supplementary Notes/Tables/
Figures S16–S29, available as Supplementary data at IJE
online). Finally, we fitted the univariate GCTA-GREML
model with disjoint halves of the genome and found little
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evidence of inflation of SNP heritability estimates due to
cryptic relatedness or population stratification
(Supplementary Note S34 and Supplementary Table S35,
available as Supplementary data at IJE online).
Discussion
Main findings
We estimate that offspring genotype, as captured by com-
mon imputed SNPs, explains 43% of the covariance be-
tween maternal pre-pregnancy BMI and offspring 15 year
BMI. In contrast, offspring genotype does not explain the
covariance between maternal BMI and offspring BW, al-
though we could not reject the possibility of a small genetic
covariance here due to the imprecision of the estimate. The
observed pattern of genetic covariance is consistent with
the hypothesis that maternal alleles inherited by the off-
spring potentially have an important confounding effect on
the association between maternal BMI and offspring child
and adolescent BMI. However, further work using meth-
ods that account for maternal genotype70 will be required
before this conclusion can be drawn.
Interpretation
To our knowledge we are the first to use bivariate GCTA-
GREML to partition the covariance between the same phe-
notype measured in the mother and offspring, although the
method has previously been used to investigate genetic co-
variance between offspring BW and cardiometabolic
traits56 and family socio-economic position and offspring
educational attainment.59 Genetic covariance was close to
zero for maternal BMI and offspring BW, suggesting that
genetic confounding (Figure 1) does not explain this associ-
ation. This is consistent with MR evidence,22 paternal neg-
ative exposure control studies,9,13,71,72 and evidence of
minimal shared genetic aetiology between BW and adult
BMI.56 In contrast, offspring genotype explained almost
half of the covariance between maternal BMI and offspring
Figure 2. Estimates of phenotypic covariance (CovP), genetic covariance (CovG) and the ratio of CovG to CovP, between maternal BMI and offspring
phenotype, from the combined cohorts (pooled IPD estimates). All variables were standardized to give mean zero and variance one in the combined
cohorts, therefore phenotypic covariances are equivalent to Pearson correlation coefficients. If CovG and CovE (the residual covariance) are opposite
in sign then CovG:CovP may be negative or >1; in this case CovG:CovP cannot be interpreted as a proportion, but still gives an indication of the extent
to which phenotypic covariance is explained by genotype. BW, birth weight, BMI, body mass index.
Table 2. Correlation matrices for maternal and offspring phenotypic variables. Values are Pearson correlation coefficients
Cohort Phenotype Birth weight 1 year BMI 5 year BMI 10 year BMI 15 year BMI 31 year BMI 46 year BMI
NFBC1966 Maternal BMI 0.22 0.13 0.16 0.22 0.22 0.18 0.16
Birth weight 0.22 0.20 0.15 0.11 0.06 0.06
1 year BMI 0.49 0.32 0.27 0.17 0.12
5 year BMI 0.66 0.53 0.35 0.26
10 year BMI 0.77 0.50 0.40
15 year BMI 0.58 0.49
31 year BMI 0.80
NFBC1986 Maternal BMI 0.19 0.09 0.19 0.25 0.27
Birth weight 0.18 0.18 0.13 0.08
1 year BMI 0.53 0.34 0.22
5 year BMI 0.75 0.61
10 year BMI 0.77
ALSPAC Maternal BMI 0.13 0.09 0.19 0.32 0.35
Birth weight 0.20 0.18 0.13 0.10
1 year BMI 0.44 0.25 0.20
5 year BMI 0.50 0.39
10 year BMI 0.79
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BMI in late childhood and adolescence, which is consistent
with an important role for genetic confounding for this lat-
ter association. However, our present data are insufficient
to firmly draw this conclusion: because of the correlation
between offspring genotype and maternal genotype, our es-
timate of genetic covariance could include a contribution
from any effects of maternal genotype on offspring BMI
via the offspring’s prenatal or postnatal environment, in-
cluding any causal intrauterine effect. Data from a recent
study suggest that parental BMI-increasing genotype does
not have a large indirect effect on offspring BMI via the
offspring’s environment,73 which in combination with our
data would suggest an important role for genetic
confounding, consistent with MR,11,23 within sibship
analyses,24,25 and paternal negative exposure control stud-
ies.8–13,26 In future work it will be important use the ma-
ternal GCTA-GREML model70 to test for maternal genetic
effects on childhood BMI, which if absent would provide
more evidence for the presence of genetic confounding
when considered in combination with our present results.
It should also be noted that our estimate of genetic covari-
ance only takes into account genetic variation captured by
common imputed SNPs, and therefore represents a lower
bound on the true genetic covariance.
Simulation studies suggest that the GCTA-GREML
model is robust to violation of several of its assumptions.74
However, GCTA-GREML estimates can be biased if causal
genetic variants have dissimilar MAF or linkage disequilib-
rium (LD) properties to the SNPs used to calculate the
GRM.36,62,74,75 A recent simulation study by Evans et al.37
concluded that MAF stratified (MS) or LD and MAF strati-
fied (LDMS) GCTA-GREML models are most robust to
these potential biases; unfortunately we had insufficient
sample size to implement GCTA-GREML-MS or GCTA-
GREML-LDMS. However, we are reassured by the empiri-
cal results presented by Evans et al.: in the UK Biobank
single-component-GCTA-GREML (GCTA-GREML-SC)
using imputed SNPs with MAF >0.01 gave a similar SNP
heritability estimate for BMI to the gold standard GCTA-
GREML-LDMS-I model.37 Given that we used SNPs with
MAF >0.01 for our primary GCTA-GREML-SC analyses,
it seems unlikely that our estimates for the ratio of genetic
to phenotypic covariance are substantively affected by
MAF or LD related biases.
Strengths and Limitations
Our study has several important strengths. We analysed
rich prospective data from three birth cohorts, collected
from early pregnancy to adolescence (and until middle age
in one study). Our use of bivariate GCTA-GREML en-
abled inference on the combined effects of hundreds or
thousands of genetic variants that individually would not
be observable. Furthermore, we meta-analysed data from
three cohorts, giving sufficient sample size to obtain statis-
tically robust evidence for genetic covariance. However,
replication in other birth cohorts would be desirable, par-
ticularly as the mothers in our cohorts were lean compared
with many present-day populations in high-income coun-
tries.5 Our primary pooled IPD estimates were not mean-
ingfully changed when we instead used standard
meta-analysis with a random effects model, relaxing the as-
sumption of effect homogeneity (Supplementary Notes/
Tables/Figures S41–S47, available as Supplementary data
at IJE online). We conducted extensive sensitivity analyses
to explore the likelihood of bias due to confounding by
familial environment45 or population stratification76,77
(Supplementary Notes/Tables/Figures S20–S29, S34 and
S35, available as Supplementary data at IJE online). Given
reassuring results from analyses in which we (i) varied the
relatedness exclusion threshold, (ii) fitted a large number
of principal components as fixed effects, and (iii) used dis-
joint halves of the genome to test for inflation due to popu-
lation structure, we feel that neither coarse nor fine
population structure are likely to pose a serious threat to
the validity of our findings.
Several limitations apply to this work. First, assortative
mating has been observed for BMI,78 and the implications
for heritability estimation using GCTA-GREML are cur-
rently unclear. Second, selection bias may occur even in
studies such as ours that estimate genetic effects.79 We
note that associations between maternal BMI and offspring
BW were similar in the samples used for our main analyses
and the larger sample of live born babies at baseline
(Supplementary Note S48 and Supplementary Table S49,
available as Supplementary data at IJE online), suggesting
that this phenotypic association is unlikely to be meaning-
fully affected by selection bias. Although we are unable to
rule out an effect of selection bias on our genetic covari-
ance estimates, it seems unlikely that such an effect would
be of sufficient magnitude to wholly account for our
results. Finally, weight at birth and BMI from childhood to
adulthood are imperfect proxy measures for adiposity.
However, there is evidence that the correlation with di-
rectly measured adiposity is strong for child and adult
BMI80,81 and moderate for neonatal weight.82
Conclusion
In conclusion, our data are consistent with, although do
not confirm, the hypothesis that genetic confounding
explains a substantial part of the association between ma-
ternal pre-pregnancy BMI and offspring adolescent BMI. It
will be important to confirm whether this is the case,
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because if there is substantial genetic confounding then in-
tervention to reduce maternal pre-pregnancy BMI with the
aim of reducing offspring obesity risk will have a smaller
effect than if such confounding did not exist.
Supplementary data
Supplementary data are available at IJE online.
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